XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2023
Oct. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,544,592 $ 1,417,608
Short-term investments 150,846 147,913
Total cash, cash equivalents and short-term investments 1,695,438 1,565,521
Accounts receivable, net 779,892 796,091
Inventories 256,426 211,927
Prepaid and other current assets 429,179 439,130
Total current assets 3,160,935 3,012,669
Property and equipment, net 546,439 483,300
Operating lease right-of-use assets, net 576,727 559,090
Goodwill 3,888,249 3,842,234
Intangible assets, net 357,113 386,446
Deferred income taxes 774,391 670,653
Other long-term assets 486,878 463,695
Total assets 9,790,732 9,418,087
Current liabilities:    
Accounts payable and accrued liabilities 701,816 809,403
Operating lease liabilities 78,056 54,274
Deferred revenue 1,968,808 1,910,822
Total current liabilities 2,748,680 2,774,499
Long-term operating lease liabilities 591,667 581,273
Long-term deferred revenue 191,413 154,472
Long-term debt 20,201 20,824
Other long-term liabilities 365,949 327,829
Total liabilities 3,917,910 3,858,897
Redeemable non-controlling interest 35,877 38,664
Stockholders’ equity:    
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 par value: 400,000 shares authorized; 152,251 and 152,375 shares outstanding, respectively 1,523 1,524
Capital in excess of par value 1,330,072 1,487,126
Retained earnings 6,075,009 5,534,307
Treasury stock, at cost: 5,010 and 4,886 shares, respectively (1,428,748) (1,272,955)
Accumulated other comprehensive income (loss) (145,997) (234,277)
Total Synopsys stockholders’ equity 5,831,859 5,515,725
Non-controlling interest 5,086 4,801
Total stockholders’ equity 5,836,945 5,520,526
Total liabilities, redeemable non-controlling interest and stockholders’ equity $ 9,790,732 $ 9,418,087